Sat, Jan 13, 2018
Spark Therapeutics plans to launch its recently approved Luxturna treatment for an inherited genetic mutation that causes blindness in March
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.